<p>Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.</p>.<p><strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</a></strong></p>.<p>The company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call.</p>.<p>Shares of the company rose as much as 5.3% to a two-week high in early trade, and were last up 3.5% at 0408 GMT.</p>
<p>Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has obtained regulatory approval to conduct clinical trials of antiviral drug favipiravir, a potential treatment for COVID-19.</p>.<p><strong><a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates.html" target="_blank">CORONAVIRUS SPECIAL COVERAGE ONLY ON DH</a></strong></p>.<p>The company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call.</p>.<p>Shares of the company rose as much as 5.3% to a two-week high in early trade, and were last up 3.5% at 0408 GMT.</p>